A review of novel biomarkers and imaging techniques for assessing the severity of chemotherapy-induced peripheral neuropathy
Author:
- 8 November 2020
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 16 (12) , 1147-1158
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a potentially persistent late toxicity of most common anticancer regimens. There is still a huge lack in CIPN assessment in clinical trials; therefore, biomarkers, both neuroimagery and molecular, could fill this gap. In this review the first applications of high-resolution ultrasound (HRUS), magnetic resonance imaging (MRI) are discussed; different molecular biomarkers first report in CIPN are also addressed, broadening the spectrum of potential molecular candidates beyond pharmacogenomics. At the present moment, neuroimaging and biomarkers are not yet part of the clinical practice for CIPN management, but they deserved to be tested since they could be a valuable surrogate endpoint in a clinical trial. To ascertain the appropriateness of (a) potential biomarker(s), it is crucial to design a clinical trial based on sound design and taking advantage of international, multidisciplinary initiatives, such as the Toxic Neuropathy Consortium.Keywords
This publication has 95 references indexed in Scilit:
- Superficial fibular neuropathy: Complementary role of ultrasoundMuscle & Nerve, 2013
- Nerve growth factor: from the early discoveries to the potential clinical useJournal of Translational Medicine, 2012
- Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available toolsEuropean Journal of Cancer, 2010
- Acute Abnormalities of Sensory Nerve Function Associated With Oxaliplatin-Induced NeurotoxicityJournal of Clinical Oncology, 2009
- Thalidomide and sensory neurotoxicity: a neurophysiological studyJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Vascularization of the Dorsal Root Ganglia and Peripheral Nerve of the Mouse: Implications for Chemical-Induced Peripheral Sensory NeuropathiesMolecular Pain, 2008
- Mitochondrial-Mediated Disregulation of Ca2+ Is a Critical Determinant of Velcade (PS-341/Bortezomib) Cytotoxicity in Myeloma Cell LinesCancer Research, 2005
- Magnetic Resonance NeurographyMagnetic Resonance in Medicine, 1992
- High-resolution sonography of the recurrent laryngeal nerve: anatomic and pathologic considerationsAmerican Journal of Roentgenology, 1985
- Vascular permeability and neurotoxicity.Environmental Health Perspectives, 1978